Trials / Conditions / Stage III Bladder Urothelial Carcinoma

Stage III Bladder Urothelial Carcinoma

5 registered clinical trials studyying Stage III Bladder Urothelial Carcinoma.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and S NCT03609216	Alliance for Clinical Trials in Oncology	Phase 2
Withdrawn	Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer NCT02944357	Mayo Clinic	N/A
Terminated	Robotic or Open Radical Cystectomy in Treating Patients With Bladder Cancer NCT02699853	University of Southern California	N/A
Terminated	Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder NCT02494635	University of Southern California	—
Completed	Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer NCT02437370	University of California, Davis	Phase 1